Jeffrey S. Hatfield insider trades

Open-market stock purchases and sales by Jeffrey S. Hatfield, Director at Vir Biotechnology, Inc, from SEC Form 4 filings since Jun 2, 2014.

Recent trades

DateStockTradeValue
May 27, 2026VIR Vir Biotechnology, IncBought (not open market)—
May 27, 2026VIR Vir Biotechnology, IncBought (not open market)—

Companies traded

  • VIR Vir Biotechnology, Inc: other filings, last May 27, 2026
  • VRDN Viridian Therapeutics, Inc.\DE: other filings, last Feb 4, 2021
  • MGEN Miragen Therapeutics, Inc: other filings, last May 21, 2020
  • LIFE aTYR PHARMA Inc: other filings, last May 6, 2020
  • ZFGN Zafgen, Inc: other filings, last Feb 22, 2018
  • NVIV Invivo Therapeutics Holdings Corp: other filings, last Jan 19, 2018
  • VTAE Vitae Pharmaceuticals, Inc: 2 sales, last Oct 25, 2016
  • AMBI Ambit Biosciences Corp: other filings, last Nov 10, 2014

Get free alerts when Jeffrey S. Hatfield files a new trade →